Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

NCT06664138 is registered in ClinicalTrials.gov with Yeongseok Yun as lead sponsor.

NCT NCT06664138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06664138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment
Lead sponsor
Yeongseok Yun
Phase
Phase 4
Overall status
Completed
Start date
April 28, 2023
Completion date
January 31, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar, major depression disorders, schizoaffective disorder, schizophenia disorder